Provided by Tiger Trade Technology Pte. Ltd.

LIVZON PHARMA

24.980
0.000
Volume:888.24K
Turnover:22.22M
Market Cap:22.18B
PE:9.35
High:25.140
Open:24.980
Low:24.820
Close:24.980
52wk High:28.238
52wk Low:18.750
Shares:888.00M
HK Float Shares:300.00M
Volume Ratio:0.67
T/O Rate:0.30%
Dividend:2.83
Dividend Rate:11.32%
EPS(LYR):2.670
ROE:12.42%
ROA:5.31%
PB:1.45
PE(LYR):9.35
PS:1.84

Loading ...

LIVZON PHARMA Announces Special Interim Dividend of RMB 10.20 Per Ten Shares

Stock News
·
Sep 08

Hong Kong Stock Market Flash | LIVZON PHARMA (01513) Climbs Nearly 3% Following Official Approval of Leikangchita Monoclonal Antibody Injection

Stock News
·
Sep 07

Livzon Pharma Schedules 2026 First EGM; Shareholders Must Register by 18 September

Bulletin Express
·
Sep 03

Livzon Pharma Reports No Change in Share Capital for August 2026

Bulletin Express
·
Sep 01

AH Share Premium Report: August 31 Market Close

Stock News
·
Aug 31

LIVZON PHARMA Secures Regulatory Approval for Subcutaneous Injection Drug

Stock News
·
Aug 27

Livzon Pharma Schedules 8 September 2026 Board Meeting to Weigh Special Dividend

Bulletin Express
·
Aug 27

LIVZON PHARMA Extends Decline as Q2 Net Profit Plunges 45% on Weak Chemical and TCM Segments

Stock News
·
Aug 25

Hong Kong Stocks Close: Hang Seng Falls 1.89% as Optical Communication Stocks Plunge, Alibaba Drops 8% on $10.2B AI-Focused Share Placement

Stock News
·
Aug 24

AH Share Premium Rankings: Market Close Update for August 24

Stock News
·
Aug 24

Livzon Pharma Boosts Shareholding in API, Intermediate Producer

MT Newswires Live
·
Aug 21

Livzon Pharma Releases 2026 Interim Report; Outlines Access and Request Procedures

Bulletin Express
·
Aug 21

Livzon Pharma to Lift Stake in Xinbeijiang Pharma to 90.64% via RMB106.70 Million Connected Share Purchase

Bulletin Express
·
Aug 21

Livzon Pharma: H1 2026 Revenue Drops 20.28%, Net Profit Slips 27.23% as Pipeline Investment Accelerates

Bulletin Express
·
Aug 21

Livzon Pharma releases Interim Report 2026 online, details shareholder communication arrangements

Bulletin Express
·
Aug 21

Earning Preview: LIVZON PHARMA Q2 revenue is expected to decrease by 5.79%, and institutional views are constructive

Earnings Agent
·
Aug 14

Livzon Pharma Sets 21 August 2026 Board Meeting to Approve 1H 2026 Interim Results

Bulletin Express
·
Aug 06

Livzon Receives China Drug Registration Certificate for Decoction Granules for Phlegm; Hong Kong Shares Slide 3%

MT Newswires Live
·
Jul 24

LIVZON PHARMA's Subsidiary Secures Drug Registration Certificate for Banxia Baizhu Tianma Decoction Granules

Stock News
·
Jul 23

Livzon Pharma Reports No Change in Share Capital; Confirms Public-Float Compliance for June 2026

Bulletin Express
·
Jul 02